Share the post "Shareholding Pattern: Shareholding Pattern Ajanta Pharma Ltd. An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Ajanta Pharma Ltd. has unveiled its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This comprehensive report offers a deep dive into the company’s shareholding landscape, including details on Promoters, promoter groups, Foreign investors, public investors, and government entities. Through meticulous comparative analysis, it tracks the evolution of shareholding percentages and quantities, highlighting any shifts in ownership dynamics. Investors gain invaluable insights into the company’s ownership structure and the evolving investment landscape.
Shareholder Name |
Previous Quater Quantity(In Crores) |
Current Quater Quantity(In Crores) |
Previous Quater Shares(in %) |
Current Quater Shares(in %) |
Quater to Quater Difference |
Promoters |
8.34 |
8.34 |
66.21 |
66.21 |
0 |
Public |
1.01 |
0.98 |
8.01 |
7.76 |
-0.25 % |
DII
|
2.10 |
2.20 |
16.68 |
17.49 |
+0.81 % |
FII
|
1.15 |
1.08 |
9.11 |
8.54 |
-0.57 % |
Government
|
0.00 |
0.00 |
0 |
0 |
0 |
Promoters shareholding remained stable, at 66.21% in both December 2023 and March 2024. This indicates that the promoters’ control over the company did not change during this period. DIIs (Domestic Institutional Investors) shareholding increased from 16.68% in December 2023 to 17.49% in March 2024 , indicating that domestic institutions increased their stake in the company by 0.81% . FIIs (Foreign Institutional Investors) shareholding decreased from 9.11% in December 2023 to 8.54% in March 2024 ,indicating that foreign institutions reduced their investments by 1.5% in the company during the quarter. This suggests a pullback in their investment .During quater from December 2023 to March 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.
Let’s delve deeper into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name |
Previous Quarter Quantity (In Crores) |
Current Quarter Quantity (In Crores) |
Previous Quater Shares (in %) |
Current Quater Shares (in %) |
Quater-to-Quater Difference (%) |
Key Managerial Personnel |
0.004 |
0.002 |
0.03 |
0.02 |
-0.01 % |
Resident Individuals holding nominal share capital up to Rs. 2 lakhs |
0.815 |
0.795 |
6.47 |
6.31 |
-0.16 % |
Non Resident Indians (NRIs) |
0.041 |
0.040 |
0.33 |
0.32 |
-0.01 % |
Bodies Corporate |
0.036 |
0.030 |
0.28 |
0.24 |
-0.04 % |
Any Other (specify) |
0.025 |
0.023 |
0.2 |
0.18 |
-0.02 % |
LLP |
0.006 |
0.004 |
0.04 |
0.03 |
-0.01 % |
Observations indicate a sizeable -0.01 % variance in Key Managerial Personnel’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.16 % variance in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.01 % variance in Non Resident Indians (NRIs)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.04 % variance in Bodies Corporate’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.02 % variance in Any Other (specify)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.01 % variance in LLP’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.
Shareholder Name |
Previous Quarter Quantity (In Crores) |
Current Quarter Quantity (In Crores) |
Previous Quater Shares (in %) |
Current Quater Shares (in %) |
Quater-to-Quater Difference (%) |
Mutual Funds/ |
1.746 |
1.859 |
13.86 |
14.76 |
+ 0.9 % |
Hdfc Large And Mid Cap Fund |
0 |
0.131 |
0 |
1.04 |
+1.04% |
Kotak Small Cap Fund |
0.154 |
0.156 |
1.23 |
1.24 |
+ 0.01 % |
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund |
0.393 |
0.377 |
3.12 |
2.99 |
-0.13 % |
Uti Flexi Cap Fund |
0.398 |
0.388 |
3.16 |
3.08 |
-0.08 % |
Alternate Investment Funds |
0.083 |
0.071 |
0.66 |
0.56 |
-0.1 % |
Insurance Companies |
0.271 |
0.272 |
2.15 |
2.16 |
+ 0.01 % |
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 |
0.207 |
0.208 |
1.64 |
1.65 |
+ 0.01 % |
Invesco India Contra Fund |
0.130 |
0 |
1.03 |
0 |
-1.03% |
The latest quarter saw a considerable enhancement in profitability for Mutual Funds/, reflecting an uptick of 0.9 % in their net earnings. Such an outcome implies the successful implementation of sound cost optimization techniques and increased income sources, ultimately highlighting the favorable effect of the investor on the corporation’s overall monetary welfare.The latest quarter saw a considerable enhancement in profitability for Kotak Small Cap Fund, reflecting an uptick of 0.01 % in their net earnings. Such an outcome implies the successful implementation of sound cost optimization techniques and increased income sources, ultimately highlighting the favorable effect of the investor on the corporation’s overall monetary welfare.Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund decreased their stake from 2.99% in the previous quarter to 3.12% in the current quarter. It describes a decrease in stakes over consecutive quarters, specifically by -0.13 %.Uti Flexi Cap Fund decreased their stake from 3.08% in the previous quarter to 3.16% in the current quarter. It describes a decrease in stakes over consecutive quarters, specifically by -0.08 %.Alternate Investment Funds decreased their stake from 0.56% in the previous quarter to 0.66% in the current quarter. It describes a decrease in stakes over consecutive quarters, specifically by -0.1 %.The latest quarter saw a considerable enhancement in profitability for Insurance Companies, reflecting an uptick of 0.01 % in their net earnings. Such an outcome implies the successful implementation of sound cost optimization techniques and increased income sources, ultimately highlighting the favorable effect of the investor on the corporation’s overall monetary welfare.The latest quarter saw a considerable enhancement in profitability for Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110, reflecting an uptick of 0.01 % in their net earnings. Such an outcome implies the successful implementation of sound cost optimization techniques and increased income sources, ultimately highlighting the favorable effect of the investor on the corporation’s overall monetary welfare.Hdfc Large And Mid Cap Fund had no shares in the previous quarter but now holds 1.04% of shares in the current quarter.Invesco India Contra Fund had 1.03% of shares in the previous quarter but exited in the current quarter.
Shareholder Name |
Previous Quarter Quantity (In Crores) |
Current Quarter Quantity (In Crores) |
Previous Quater Shares (in %) |
Current Quater Shares (in %) |
Quater-to-Quater Difference (%) |
Foreign Portfolio Investors Category I |
1.119 |
1.050 |
8.89 |
8.34 |
-0.55 % |
Foreign Portfolio Investors Category II |
0.027 |
0.026 |
0.22 |
0.2 |
-0.02 % |
Profitability dwindled by -0.55 % for Foreign Portfolio Investors Category I in comparison to the preceding quarter. To secure a foundation for prospective sustainable progress, investigating the factors prompting this decline is vital.Profitability dwindled by -0.02 % for Foreign Portfolio Investors Category II in comparison to the preceding quarter. To secure a foundation for prospective sustainable progress, investigating the factors prompting this decline is vital.
[my_shortcode1 values=”Ajanta Pharma Ltd. “]